Results 101 to 110 of about 5,456,142 (288)
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B [PDF]
Chronic hepatitis B (CHB) poses a major global public health challenge and is a leading cause of cirrhosis and liver cancer. Hepatic steatosis is common in individuals with CHB compared to the non-CHB population and is particularly prevalent in hepatitis
Zhang, Saisai +7 more
core +2 more sources
JPGN Reports, EarlyView.Abstract Hereditary fructose intolerance (HFI) typically presents in infancy with acute metabolic crisis upon the introduction of fructose. We report a case of a 13‐year‐old female with chronic abdominal pain, short stature, and persistent mild transaminitis.
Alexandra Hurlock +4 more
wiley +1 more source
Advanced hepatic fibrosis is the most relevant prognostic factor in patients with metabolic (dysfunction)–associated fatty liver disease (MAFLD), being a significant predictor of both liver-related and all-cause mortality.
Kaya, Eda, Yılmaz, Yusuf
core +1 more source
JPGN Reports, EarlyView.ABSTRACT Esophageal varices (EV) need monitoring in patients with portal hypertension. In 2022, a single‐use ultra‐slim (3.5 mm) gastroscope was approved for use in children and adults. This study evaluated if an ultra‐slim gastroscope could evaluate, grade, and corroborate the presence of EV in sedated pediatric patients as compared to standard oral ...
Vishruti Patel +6 more
wiley +1 more source
Chronic liver disease is one of the leading causes of morbidity and mortality worldwide. Cirrhosis of the liver is the most advanced form of chronic liver disease and the 12th leading cause of death worldwide.
Alina Mihaela Constantin +9 more
core +1 more source
JPGN Reports, EarlyView.Abstract The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) recognized the need to define research priorities and identify knowledge gaps to guide future investigations in pediatric digestive health. Following international examples, SIGENP aimed to provide a structured framework that aligns scientific innovation with ...
Carlo Agostoni +46 more
wiley +1 more source
JSFA reports, EarlyView.Abstract Food processing can improve safety, shelf life, digestibility and sensory quality, but it can also alter the food matrix, remove microbiota‐accessible substrates and introduce additives or heat‐derived compounds that modify host–microbe interactions.
Elijah Kolawole Oladipo +10 more
wiley +1 more source
Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD
Molecules and Cells: Recently, the incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing due to the high prevalence of metabolic conditions, such as obesity and type 2 diabetes mellitus.
So Jung Kim, Jeongeun Hyun
doaj +1 more source
Methotrexate induced hepatotoxicity in metabolic dysfunction-associated steatotic liver disease [PDF]
Hepatotoxicity is an under-recognized and potentially fatal side effect of high-dose methotrexate (HDMTX) chemotherapy, and this risk is compounded in children with metabolic dysfunction-associated steatotic liver disease and/or metabolic-associated ...
Hashmat, Shireen +3 more
core +1 more source
Journal of Ultrasound in Medicine, EarlyView.Objectives To assess the performance of 3 ultrasound‐based liver fat quantification algorithms—tissue attenuation imaging (TAI), tissue scatter imaging (TSI; Nakagami parameter), and ultrasound‐derived fat fraction (USFF)—using magnetic resonance imaging‐derived proton density fat fraction (MRI‐PDFF) as the reference standard.
Davide Roccarina +3 more
wiley +1 more source